argenx is a biotechnology company focused on immunology and the development of antibody-based medicines. The company works with researchers and healthcare professionals to translate immunology research into treatment candidates, with programs addressing autoimmune and other immune-mediated diseases. Its public pipeline includes medicines at different stages of development and commercialization. argenx also describes a collaborative research model through its Immunology Innovation Program, which supports the discovery and advancement of potential therapies.
Claim this company profile
Please sign in to claim this profile.
Company reviews
No approved reviews yet.
Please sign in to write a review. One review per account and company.